Annovis Bio, Inc. · NYSE:ANVS
Empery Asset Management, LP reported a 5.64% stake in Annovis Bio, Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Jul 29, 2026
Empery Asset Management, LP reported a 5.64% stake in Annovis Bio, Inc., 2,401,476 shares, as a passive investor on Jun 30, 2026. Filed Jul 29, 2026 (Schedule 13G).
- Stake
- 5.64%
- Shares
- 2,401,476
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 2 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| Empery Asset Management, LP | 5.64% | 2,401,476 |
| Ryan M. Lane | 5.64% | 2,401,476 |
Source
Related
- Annovis Bio, Inc.
- Empery Asset Management, LP
- Annovis Bio, Inc. shareholders
- Schedule 13G/A · Empery Asset Management, LP · Oct 15, 2026
- Schedule 13G · Highbridge Capital Management LLC · Aug 14, 2026
- Form 4 · Hoffman Michael B · May 21, 2026
- Form 4 · Hoffman Michael B · Apr 3, 2026
- Schedule 13G/A · CVI Investments, Inc. · May 12, 2025
- Schedule 13G · CVI Investments, Inc. · Feb 10, 2025